Kimia Farma Tbk PT
IDX:KAEF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Kimia Farma Tbk PT
Free Cash Flow
Kimia Farma Tbk PT
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
Free Cash Flow
Rp101B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-26%
|
CAGR 10-Years
14%
|
|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Free Cash Flow
Rp914.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
11%
|
CAGR 10-Years
6%
|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
Free Cash Flow
Rp2.5T
|
CAGR 3-Years
83%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
5%
|
|
|
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
|
Free Cash Flow
Rp93.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
16%
|
CAGR 10-Years
-6%
|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
Free Cash Flow
Rp837.4B
|
CAGR 3-Years
38%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
Free Cash Flow
-Rp532.6B
|
CAGR 3-Years
-135%
|
CAGR 5-Years
-140%
|
CAGR 10-Years
N/A
|
|
Kimia Farma Tbk PT
Glance View
PT Kimia Farma Tbk engages in the production and distribution of healthcare products. The company is headquartered in Jakarta, Dki Jakarta and currently employs 11,668 full-time employees. The company went IPO on 2001-07-04. The firm produces medical devices and chemical materials. The firm is also involved in producing vegetable oil, iodine, and salts. Its products include Glucokaf, Diazink, Oracef, Kifarox, Magacid Suspension, Magaside Chewable Tablets, Nitrocafe Retarded, Nitrocafe Retard Forte, Trinolon, Raistine, VAGIZOL, Neviral, Hiviral Tablet, Duviral, Codipront Cum Expectorant, RETHAPHYL SR, and SUPRAFLU. Its generic products include PETHIDIN Hcl, PARACETAMOL, Diclofenac Sodium, MEPHANAMIC ACID, ANTALGIN, ANTASIDE DOEN, PYRANTEL, ALBENDAZOLE, METRONIDAZOLE TABLET, NEO BLOOD ADDING TABLET, FERROUS SULOATE SYRUP, DIMENHYDRINATE, ACYCLOVIR, AMBROXOL HCL, CHLOROQUINE, CHLORPROMAZINE HCL, CODEIN, CLOPIDOGREL, ERGOTAMINE COFFEE, METHYLERGOMETRINE TABLET SALUTE, MELOXICAM, and Pherphenazine.
See Also
What is Kimia Farma Tbk PT's Free Cash Flow?
Free Cash Flow
101B
IDR
Based on the financial report for Dec 31, 2025, Kimia Farma Tbk PT's Free Cash Flow amounts to 101B IDR.
What is Kimia Farma Tbk PT's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
14%
